Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally.
*Investment opportunity - low risk* The summary below is the result of hours of study - I go to sleep and dream of charts, and not by choice! If you find this idea of value please like and share. On the above monthly chart price action has been in a downtrend for 20 years to the day. A number of technical indicators and three oversold conditions (orange...
Fundamental Analysis: Agenus Inc. is an immuno-oncology company that develops technologies to treat cancers and other infectious diseases. One drug that they are developing, AGEN1181 , has undergone phase 1/2 safety trials. The results from these trials were released on February 9, 2021, and the results will be presented at AACR on April 10, 2021. AGEN1181 is...
options trading that AGEN will go long around 3.25 earnings in 5 days trade invalid around 2.80 or personal stop loss
Bullish Pennant Descending volume during formation PPS above 50MA and 200MA RS above 0, and ascending ATR Ascending R/R ratio above 5 200MA ascending 250RSI above 50 PT = 7.32$
Check the chart. Like, follow, and enjoy! Cheers!
I have been closely following AGEN after their approval of the Shingrix Vaccine. After a couple years of shortage issues, sales this year should be killer (they are partnered with GSK). Look for more positive news to come in about their oncology pipeline as well. Weekly MACD cross, volume picking up. 1st target 5.00, selling part of my position there and...
1. Keeping above 3.9 and potential entry for target 4.5. 2. Breaking below, and the bottom channel can be tested. Not for any advise Just an Idea.
Very nice channel with positive slope. Not for any advise Just an Idea.
AGEN has retraced 61.8% of the first impulse leg higher and is ready to rally again.
Ascending Triangle, waiting for confirmation Pros: Descending volume during formaiton Volume on break out PPS above 50MA and 200MA 250RSI above 50 RS above 0 and climbing 200MA flat/climbing ATR climbing, more volatile If confirmed: PT = 7,25$
AGEN - Triangle Breakout and 50/200 MA Crossed
Contextual immersion trading strategy idea. Agenus Inc., a clinical-stage immuno-oncology company, engages in advancing a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer. The demand for shares of the company still looks higher than the supply. This and other conditions can cause a rise in the...